USANA Health Sciences Inc Cash Flow Conversion Efficiency
USANA Health Sciences Inc cash flow conversion efficiency. Based on the latest financial reports, USANA Health Sciences Inc (USNA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.76 Million) by net assets ($594.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of USANA Health Sciences Inc (1995–2025)
Cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. This chart illustrates how USANA Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View USANA Health Sciences Inc stock price for real-time trading data and today's change.
USANA Health Sciences Inc Cash Flow Conversion Ratio Explained
USANA Health Sciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
USANA Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of USANA Health Sciences Inc ranked by their cash flow conversion efficiency. Also see how much is USANA Health Sciences Inc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Youngtek Electronics
TWO:6261
|
0.041x |
|
Lionheart Holdings
NASDAQ:CUB
|
0.000x |
|
T&L Co. Ltd
KQ:340570
|
0.096x |
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
0.070x |
|
Shenzhen Wongtee International Enterprise Co Ltd
SHE:000056
|
-0.023x |
|
INTERGRATED DIA.H DL 025
F:8I8
|
0.096x |
|
Information Services Group Inc
NASDAQ:III
|
-0.009x |
|
Standard Biotools Inc
NASDAQ:LAB
|
-0.019x |
Annual Cash Flow Conversion Efficiency for USANA Health Sciences Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. Review USNA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $586.27 Million | $22.35 Million | 0.038x | -63.35% |
| 2024-12-31 | $586.33 Million | $60.99 Million | 0.104x | -26.78% |
| 2023-12-31 | $497.20 Million | $70.64 Million | 0.142x | -40.59% |
| 2022-12-31 | $434.47 Million | $103.90 Million | 0.239x | -22.05% |
| 2021-12-31 | $395.12 Million | $121.23 Million | 0.307x | -15.52% |
| 2020-12-31 | $441.65 Million | $160.40 Million | 0.363x | +0.79% |
| 2019-12-31 | $351.71 Million | $126.73 Million | 0.360x | -7.35% |
| 2018-12-31 | $391.15 Million | $152.12 Million | 0.389x | +14.11% |
| 2017-12-31 | $363.21 Million | $123.78 Million | 0.341x | -19.10% |
| 2016-12-31 | $325.29 Million | $137.03 Million | 0.421x | +6.14% |
| 2015-12-31 | $280.85 Million | $111.47 Million | 0.397x | -13.15% |
| 2014-12-31 | $230.16 Million | $105.19 Million | 0.457x | +20.39% |
| 2013-12-31 | $260.52 Million | $98.89 Million | 0.380x | -24.10% |
| 2012-12-31 | $185.57 Million | $92.81 Million | 0.500x | +24.06% |
| 2011-12-31 | $173.91 Million | $70.11 Million | 0.403x | -11.48% |
| 2010-12-31 | $145.17 Million | $66.11 Million | 0.455x | +4.31% |
| 2009-12-31 | $74.37 Million | $32.47 Million | 0.437x | -69.76% |
| 2008-12-31 | $31.84 Million | $45.96 Million | 1.444x | -2.52% |
| 2007-12-31 | $38.64 Million | $57.22 Million | 1.481x | +47.30% |
| 2006-12-31 | $60.20 Million | $60.52 Million | 1.005x | -4.24% |
| 2005-12-31 | $45.74 Million | $48.02 Million | 1.050x | +31.55% |
| 2004-12-31 | $47.84 Million | $38.18 Million | 0.798x | -0.19% |
| 2003-12-31 | $44.37 Million | $35.48 Million | 0.800x | -9.26% |
| 2002-12-31 | $18.09 Million | $15.94 Million | 0.881x | +28.64% |
| 2001-12-31 | $14.53 Million | $9.95 Million | 0.685x | +116.77% |
| 2000-12-31 | $12.87 Million | $4.07 Million | 0.316x | -72.82% |
| 1999-12-31 | $12.90 Million | $15.00 Million | 1.163x | +235.67% |
| 1998-12-31 | $30.60 Million | $10.60 Million | 0.346x | -5.84% |
| 1997-12-31 | $19.30 Million | $7.10 Million | 0.368x | +8.61% |
| 1996-12-31 | $12.40 Million | $4.20 Million | 0.339x | -42.68% |
| 1995-12-31 | $6.60 Million | $3.90 Million | 0.591x | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more